Mr. Speaker, we learned from a report on French CBC TV that two children had life-threatening reactions to an experimental drug, ALG, that was approved by Health Canada and administered to them at Sainte-Justine Hospital. However, this experimental drug was never approved or authorized for export by the U.S. authorities. This
drug is the subject of a criminal investigation after two people died from it in the United States.
How can the Minister of Health justify her department's decision to authorize the use of ALG when this high-risk experimental drug was never approved and authorized for export by the United States since it was developed in the early 1970s?